Carolinas Wealth Consulting’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-414
| Closed | -$206K | – | 853 |
|
|
2025
Q1 | $206K | Buy |
414
+2
| +0.5% | +$995 | 0.04% | 174 |
|
|
2024
Q4 | $214K | Sell |
412
-3
| -0.7% | -$1.56K | 0.04% | 179 |
|
|
2024
Q3 | $257K | Sell |
415
-16
| -4% | -$9.9K | 0.05% | 162 |
|
|
2024
Q2 | $238K | Sell |
431
-183
| -30% | -$101K | 0.05% | 164 |
|
|
2024
Q1 | $357K | Buy |
614
+249
| +68% | +$145K | 0.07% | 124 |
|
|
2023
Q4 | $194K | Buy |
365
+85
| +30% | +$45.2K | 0.04% | 164 |
|
|
2023
Q3 | $125K | Sell |
280
-48
| -15% | -$21.4K | 0.03% | 196 |
|
|
2023
Q2 | $171K | Buy |
328
+40
| +14% | +$20.9K | 0.03% | 186 |
|
|
2023
Q1 | $166K | Sell |
288
-8
| -3% | -$4.62K | 0.04% | 190 |
|
|
2022
Q4 | $163K | Buy |
296
+196
| +196% | +$108K | 0.04% | 190 |
|
|
2022
Q3 | $51K | Sell |
100
-18
| -15% | -$9.18K | 0.01% | 321 |
|
|
2022
Q2 | $64K | Buy |
118
+4
| +4% | +$2.17K | 0.02% | 304 |
|
|
2022
Q1 | $67K | Sell |
114
-4
| -3% | -$2.35K | 0.01% | 309 |
|
|
2021
Q4 | $79K | Buy |
118
+4
| +4% | +$2.68K | 0.02% | 295 |
|
|
2021
Q3 | $65K | Buy |
114
+1
| +0.9% | +$570 | 0.02% | 301 |
|
|
2021
Q2 | $57K | Buy |
113
+33
| +41% | +$16.6K | 0.01% | 348 |
|
|
2021
Q1 | $37K | Buy |
80
+20
| +33% | +$9.25K | 0.01% | 413 |
|
|
2020
Q4 | $28K | Sell |
60
-135
| -69% | -$63K | 0.01% | 426 |
|
|
2020
Q3 | $86K | Buy |
195
+179
| +1,119% | +$78.9K | 0.03% | 214 |
|
|
2020
Q2 | $6K | Buy |
+16
| New | +$6K | ﹤0.01% | 384 |
|